Bitchute odysee Telegram Feed

FDA’s Proposal to Curb Mercury Fillings Was Secretly Overruled by Senior Government Officials

A recent news report revealed an FDA proposal from 2011 that would have told dentists to avoid using mercury fillings in pregnant women, nursing mothers, children, and people with mercury allergies, kidney diseases, and neurological problems. It also contained a more general alert to dentists asking them to consider alternatives to mercury fillings on all patients. Unfortunately, the FDA’s proposal was rejected by senior officials at the Department of Health and Human Services (HHS) after a so-called cost-benefit analysis was performed. It was then hushed up. Mercury is a deadly neurotoxin. When mercury gets into the central nervous system, it has a half-life of between fifteen and thirty years. Once it’s inhaled into the lungs, it enters the bloodstream and can accumulate in the kidneys, liver, and brain. The effects of exposure to mercury are devastating. Studies have shown mercury fillings to be associated with Alzheimer’s disease, autoimmunity, kidney dysfunction, infertility, polycystic ovary syndrome, neurotransmitter imbalances, food allergies, multiple sclerosis, thyroid problems, and an impaired immune system. Mercury in the nervous system is especially harmful, causing all sorts of problems: tremors, insomnia, polyneuropathy, headaches, weakness, blurred vision, and more. That the proposed FDA warning, half-hearted as it was, remained secret for so long is especially worrisome. How much other information is being withheld from the public at the behest of special interests—or for other political reasons? This story is also a reminder that even the FDA has overseers who exercise control over it. In this case, the agency tried to move in the right direction and was overruled by its political masters. Action Alert! Write to the Department of Health and Human Services and tell them how disappointed you are to learn that this warning from the FDA was rejected and then kept secret. Mercury is a dangerous neurotoxin and should be removed from all fillings to protect the health and safety of all Americans. Please send your message immediately.

Read More

New Federal Bill Lowers Standards for Experimental Vaccine Licensing

It has only been a few weeks since the forced vaccination lobby rammed a bill (SB 277) through the California legislature eliminating the personal belief vaccine exemption so children will have to get dozens of doses of federally recommended vaccines or be denied a school education. While California was being subjected to one of the most aggressive and expensive state lobbying campaigns ever mounted by the pharmaceutical industry in partnership with medical trade associations funded by industry and government that same lobby was pulling an even bigger fast one on the American people in Washington, D.C. Here comes the 21st Century Cures Act, which is a Pharma-driven bill blessed by the FDA that seriously compromises the integrity of the FDA drug and vaccine licensing process. The 362-page bill sailed through the U.S. House of Representatives on July 10, 2015 and mandates that about $9 billion dollars be given to NIH to develop more drugs and vaccines and $550 million be given to the FDA to fast track products to market. The 21st Century Cures Act is being sold as a way for the FDA to quickly license experimental pharmaceutical products for people suffering with rare or life threatening diseases, whether or not those products have been adequately tested. However, greasing the FDA licensure skids to make experimental drugs available for the sick and dying, who voluntarily choose to use them, is one thing, while greasing the skids to bum rush experimental vaccines to licensure that government will legally require healthy children and adults to buy and use, is something quite different.

Read More

FDA Update: Submit YOUR Comments About Over-the-Counter Homeopathic Medicines to the FDA

FDA’s two-day public hearing to gather information about the current use of products labeled as homeopathic took place in late April. The hearing focused specifically on FDA regulations of and labeling requirements for OTC homeopathic medicines. This hearing was not held to discuss the efficacy of homeopathy, the ability of individuals to practice homeopathy, or to consider the removal of homeopathic remedies from the retail market. The public hearing was the first phase of information gathering for FDA. The next phase of information gathering is a public comment period – which is now open and will remain open through June 22, 2015. YOUR assistance at this time will be invaluable!

Read More

FDA to Crack Down on Home-based Soap Makers

People who are trying to do good for their families and the planet by living a simple life based on traditional skills are facing yet another assault. Artisanal soap makers say new regulations, proposed by Senator Dianne Feinstein (D-California) and Senator Susan Collins (R-Maine), will put them out of business.

Read More

How Can Homeopathy Be Both a Useless Placebo and Dangerous at the Same Time?

The FDA wrapped up a two-day hearing recently on whether or not homeopathic remedies should be regulated like drugs. Listening to critics of homeopathy try to justify why they don't think the American public should have free access to homeopathic remedies leaves one wondering just what the real motivation is behind these criticisms. The two dominant criticisms made against homeopathic remedies are antithetical to each other. Critics complain that due to a lack of regulation homeopathic remedies are dangerous, but then they turn around and say that homeopathic remedies are simply useless sugar pills with no therapeutic effect whatsoever, and no better than a placebo. Both cannot be true. Is this the new standard of scientific scrutiny that federal agencies are using to supposedly protect the public? The FDA is clearly not concerned about homeopathic remedies because they are a danger to the public. There are no deaths associated with homeopathic remedies, and very few side effects. By contrast, FDA-approved drugs have millions of adverse side effects, including over 100,000 deaths each year. Homeopathic remedies are a danger to the FDA's monopoly on drugs, and so they clearly want to either eliminate the competition, or get in on the action and take over the market.

Read More

Is the FDA Getting Ready to Ban Homeopathy?

Homeopathy was one of the most common medical practices in the United States in the 1800s. In 1892, homeopaths in the United Stated controlled about 110 hospitals, 145 dispensaries, 62 orphan asylums and old peoples homes, over 30 nursing homes and sanitaria and 16 insane asylums. However, the pharmaceutical industry did everything it could to stomp out homeopathy, and it is not as widespread in the U.S. today as it once was. (See: American Medical Revolutions: How the AMA Took Over America.) Worldwide, homeopathy is the second largest system of health care used behind conventional pharmaceutical-based medicine. The number of homeopaths worldwide doubled between 1999 and 2009, and the number of homeopathic hospitals grew from under 2,000 to over 7,000. Currently, there are no homeopathic hospitals in the United States. There are still homeopaths practicing in the U.S., however, and we have highlighted some of their work here at Health Impact News. Their ability to help heal vaccine injuries, for example, is quite impressive. Soon, however, the FDA may take steps to further reduce or even eliminate homeopathy in the U.S., as the Alliance for Natural Health reports here.

Read More

FDA Deliberately Conceals Fraudulent Studies Regarding Drugs

A recent report shows how the FDA hides important safety information when it uncovers scientific misconduct in clinical trials of pharmaceutical drugs. The names of the drugs and the company responsible for the misconduct are concealed, journal citations are left uncorrected, and claims made on drugs’ labels are left unchanged even after it’s known that they were based on bad science.

Read More

FDA Uncovers Fraud, Incompetence, and Misconduct in Clinical Trials but Says Nothing

It is hard to defend an agency that continually acts against the best interests of the public they’re entrusted to defend. Due to the efforts of a professor and his students at the Arthur L. Carter Institute of Journalism at New York University, we have proof that the FDA is failing to warn Americans about grave concerns due to falsifications in published data. They found 60 clinical trials that had violations found by the FDA, and these trials were used for data in 78 published articles. And we’re not talking about small, innocent mistakes. The violations included fraud, incompetence, and misconduct. This means that anyone browsing a medical journal might be making decisions based on fraudulent published studies.

Read More

Federal Government Annual Report on Pesticide Residues Excludes Glyphosate

The results of government testing of our foods for pesticide residues may not be quite what we expected. Every year the Agricultural Marketing Service (AMS) targets certain food materials which they consider high risks, collects samples from warehouses and storage facilities, and tests them for a wide array of pesticides they deem likely to be present. These Pesticide Data Program (PDP) reports are one of many taxpayer funded activities designed to fulfill the agency's congressional goals and mandates. The latest published report from December 2014 reveals that the world's most widely-used herbicide, glyphosate, was not even tested. Neither were wheat products grown in the U.S. With all the glyphosate studies showing microbiome impacts and chelation of toxic minerals (aluminum), why no sampling of glyphosate? Is cost really so prohibitive with our federal budget, while we see escalating chronic health problems? Or, are the chemical companies behind the most popular herbicide in the world putting pressure on the federal government not to do anything that would put a dent in the sale of their products?

Read More

FDA Censoring Free Speech on Facebook

Amazing—the little “Like” button has the power to magically turn supplements into drugs. You will recall how the FDA threatened cherry growers and walnut producers with jail if they opened their mouths about the curative powers of these foods. Now the FDA has issued a warning letter to the Utah nutritional supplement company Zarbee’s, Inc. The most troubling part of the letter concerns Zarbee’s participation on Twitter and Facebook. The agency says that when the company “likes” their customer’s Facebook comments, they are essentially endorsing the customer’s statement. In other words, when customers say a product has helped their children stop coughing or has relieved their bronchitis, and Zarbee’s “likes” that post, the FDA believes they are essentially saying, “We certify that everything you have written is scientifically accurate,” and therefore are promoting their supplements as drugs not approved by the FDA.

Read More

Medical Bureaucracy (and FDA Regulations) Stymie Efforts to Halt Ebola

The current dearth of treatment options for Ebola is not from a lack of options, but from a zealous protection of current medical monopolies together with an overabundance of red tape. In a related article, we discussed government hostility to natural remedies that are both cheap, effective, and more readily available. In this article, we’ll look at the FDA roadblocks to more conventional treatments. The FDA is paid by drug companies and is generally friendly to them. Even so, getting a new drug or device approved is a torturous and insanely expensive process. The minimum cost these days is several hundred million dollars spent over many years. The average cost is in the billions. Technology like Nanobiosym’s “iPhone-sized device,” which can be used to detect Ebola and other diseases in less than an hour, is being delayed by needless FDA red tape. The Dallas hospital that treated three patients with Ebola had a similar device, one that could detect Ebola with high degree of confidence within a few minutes, but were prevented from using it because of FDA regulations.

Read More

FDA Targets Essentials Oils: Sees EOs as Threat to New Ebola Drugs?

The FDA issued warning letters this week to the two largest distributors of essentials oils in the United Sates, Young Living and dōTERRA. The FDA is claiming that their products are being marketed as unapproved drugs. The companies have to remove all health claims and take corrective actions, or face very serious legal action, which can include armed federal marshals coming to their warehouses and seizing all of their inventory. This is of course not the first time that the FDA has gone after companies selling natural products, products that could never be patented, for making health claims about those products. They have a history of issuing warning letters against the producers and marketers of such things as walnuts, cranberries, elderberry juice, coconut oil, and many more. The FDA requires that companies selling natural products and making health claims get their permission first, by going through a lengthy and costly drug approval process. These two companies have been around for many years, and the independent distributors have been making health claims for the essential oils for a very long time. So why is the FDA acting now?

Read More

Report: FDA Deliberately Deceptive – Poisoning Millions of Americans

US consumers are in dark about mercury in dental products—and they are kept there deliberately by the government. This is documented in a new report being released this week by Consumers for Dental Choice called “Measurably Misleading: Evidence the FDA and Dental Industry are Deliberately Deceiving American Families about Mercury Dental Fillings and Why That Now Has International Consequences.” Mercury is a known neurotoxin, yet mercury fillings presents one of the largest consumer consumption of mercury worldwide, and dental amalgam represents the largest use of mercury in consumer products in the US. We’ve also been kept in in the dark about mercury in other consumer products because of the FDA. Thimerosal, a mercury compound often found in flu vaccines, is being ignored as a danger.

Read More

New Cholesterol Drug Approval to be Fast-tracked by FDA to Highest Bidder

Fresh off recent news that more than 1,000 people have filed lawsuits for damages due to cholesterol-lowering drugs since April this year, comes the remarkable story reported in the Wall Street Journal that Regeneron Pharmaceuticals, Inc. and Sanofi SA are spending $67.5 million to purchase a voucher that will allow them to get the FDA to fast-track approval of a new class of cholesterol drugs. By purchasing this voucher, they hope to beat rival drug company Amgen, Inc. in being first to market with these new cholesterol-lowering drugs. Bloomberg Businessweek is reporting that this is a first-of-its-kind deal offered by the FDA to fast track a drug through the purchase of a voucher. However, the original voucher issued by the FDA was not even for a cholesterol lowering drug. It was originally issued to BioMarin Pharmaceutical under a 2012 law designed to reward companies for investing in drugs for rare childhood diseases. This law, which the FDA says was "intended to encourage the development of treatments for rare pediatric diseases," also allowed those awarded such vouchers to sell them to other drug companies for the development of other drugs. This has effectively created a type of legal "black market" where drug companies can sell these vouchers to the highest bidder, even though they were intended by the FDA to approve new drugs specifically for the "development of treatments for rare pediatric diseases." Since this apparently does not raise any ethical questions in the mainstream media, I will raise them here.

Read More

FDA Reverses Its Position on Daily Aspirin

If you are one of the 40 million Americans who take an aspirin every day, you may want to heed the latest warning from the US Food and Drug Administration (FDA). After many decades of promoting aspirin, the FDA now says that if you have not experienced a heart problem, you should not be taking a daily aspirin—even if you have a family history of heart disease. This represents a significant departure from FDA's prior position on aspirin for the prevention of heart attacks.

Read More

FDA Asked Big Pharma to Self-Police on Dangerous Chemicals

Phthalates are synthetic chemicals used in plastics, lubricants, insect repellants, nail polish, perfumes, and, yes, even in prescription drugs. Phthalates have a number of well known health risks and it’s been well established that patients who take drugs containing phthalates absorb that chemical into their body. In 2012, the FDA politely asked drug companies not to use phthalates in their drugs. This is despite the fact that the FDA has full power to ban phthalates. Why would the FDA issue a voluntary guidance, when they have the power to ban harmful substances outright? The answer, as always, can be reduced to three little words: “Follow the money.” Drug companies today pay a large proportion of the FDA’s budget, and FDA career personnel may hope to work for drug companies later in their career.

Read More

Why the FDA Should be Charged with Murder

No medical drug in the US can be released for public use unless and until the FDA says it is safe and effective. That’s the rule. The FDA is spitting out drug approvals month after month and year after year, and the drugs are routinely killing 100,000 people a year and maiming two million more, which adds up to a million deaths per decade and 20 million maimings per decade. The FDA and the federal government are doing nothing about it, even though they know what’s going on. This is mass murder. Not accidental death.

Read More

Food Safety Modernization Act Threatens Organic Farmers

What does the FDA know about farming? “Jack Manure,” apparently. In January 2011, after one of the most underhanded legislative maneuvers we’ve ever seen, the disastrous Food Safety Modernization Act (FSMA) was signed into law. The FSMA gave the FDA unprecedented power over American farms. And as we pointed out at the time, the FDA knows absolutely nothing about farming. In January 2013, the FDA issued draft rules for produce, decreeing that farmers would have to wait nine months between applying manure and harvesting. This will take many organic fields out of production for an entire growing season, economically crippling small farmers.

Read More

FDA Fails to Protect Against Antibiotic Resistance, Guarantees More Needless Death and Suffering

Antibiotic-resistant bacteria infect two million Americans every year, causing at least 23,000 deaths. Nearly 25 million pounds of antibiotics are administered to US livestock every year for purposes other than treating disease, such as making the animals grow bigger faster. The European Center for Disease Prevention and Control (ECDC) ruled that antibiotic resistance is a major threat to public health worldwide, and the primary cause for this man-made epidemic is the widespread misuse of antibiotics. Denmark stopped the widespread use of antibiotics in their pork industry 14 years ago. The European Union has also banned the routine use of antibiotics in animal feed over concerns of antibiotic-resistant bacteria. What’s standing in the way of curbing antibiotic use in the U.S.? In a word, industry. For instance, the American Pork Industry doesn’t want to curb antibiotic use, as this would mean raising the cost of producing pork by an estimated $5 for every 100 pounds of pork brought to market. The pharmaceutical industry is obviously against it as well.

Read More

Big Pharma Wants to Monopolize the B Vitamin You Can’t Live Without

Last week we told you about FDA’s sneak attack to ban folate, the B9 vitamin essential to human life. This week, we tell you why the drug industry may want to ban folate and keep it all to itself: it could be a ploy to make billions on a new, patented SSRI/folate combo drug.

Read More